24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
39.38% |
|
PEPTIDOMIMETIC CD40L BINDING |
30.63% |
|
CANCER |
16.25% |
|
GRASPETIDE RING FORMATION |
13.75% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
47.15% |
|
CANCER |
27.05% |
|
PEPTIDOMIMETIC CD40L BINDING |
17.12% |
|
GRASPETIDE RING FORMATION |
5.46% |
|
PLANT LIPID MUTANT SCREENING |
3.23% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
53.6% |
|
ENZYME DYNAMICS |
19.44% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
10.19% |
|
CANCER |
6.27% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
4.98% |
|
PEPTIDOMIMETIC CD40L BINDING |
2.32% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
1.06% |
|
MEMBRANE TRANSPORT |
.99% |
|
GRASPETIDE RING FORMATION |
.54% |
|
PLANT LIPID MUTANT SCREENING |
.32% |
|
ATWRI1 MUTANT SCREENING |
.27% |
|
EBOLA |
.02% |